These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 7560889)
1. Quantitative and three-dimensional analysis of human Langerhans cells in epidermal sheets and vertical skin sections. Emilson A; Scheynius A J Histochem Cytochem; 1995 Oct; 43(10):993-8. PubMed ID: 7560889 [TBL] [Abstract][Full Text] [Related]
2. Defined in situ enumeration of T6 and HLA-DR expressing epidermal Langerhans cells: morphologic and methodologic aspects. de Jong MC; Blanken R; Nanninga J; Van Voorst Vader PC; Poppema S J Invest Dermatol; 1986 Dec; 87(6):698-702. PubMed ID: 2431069 [TBL] [Abstract][Full Text] [Related]
3. Langerhans cells, immunomodulation and skin lesions. A quantitative, morphological and clinical study. Bergfelt L Acta Derm Venereol Suppl (Stockh); 1993; 180():1-37. PubMed ID: 7901956 [TBL] [Abstract][Full Text] [Related]
4. Langerhans cells in hypospadias: an analysis of Langerin (CD207) and HLA-DR on epidermal sheets and full thickness skin sections. Haid B; Reider D; Nägele F; Spinoit AF; Pechriggl E; Romani N; Fritsch H; Oswald J BMC Urol; 2019 Nov; 19(1):114. PubMed ID: 31718599 [TBL] [Abstract][Full Text] [Related]
5. Quantitative and 3-dimensional analysis of Langerhans cells in basal cell carcinoma. A comparative study using light microscopy and confocal laser scanning microscopy. Bergfelt L; Emilson A; Lindberg M; Scheynius A Br J Dermatol; 1994 Mar; 130(3):273-80. PubMed ID: 7511926 [TBL] [Abstract][Full Text] [Related]
6. PUVA therapy decreases HLA-DR+ CDIa+ Langerhans cells and epidermal cell antigen-presenting capacity in human skin, but flow cytometrically-sorted residual HLA-DR+ CDIa+ Langerhans cells exhibit normal alloantigen-presenting function. Ashworth J; Kahan MC; Breathnach SM Br J Dermatol; 1989 Mar; 120(3):329-39. PubMed ID: 2469456 [TBL] [Abstract][Full Text] [Related]
7. Contact allergens, but not irritants, alter receptor-mediated endocytosis by human epidermal Langerhans cells. Rizova H; Carayon P; Barbier A; Lacheretz F; Dubertret L; Michel L Br J Dermatol; 1999 Feb; 140(2):200-9. PubMed ID: 10733267 [TBL] [Abstract][Full Text] [Related]
8. Flow cytometrically-sorted residual HLA-DR+T6+ Langerhans cells in topical steroid-treated human skin express normal amounts of HLA-DR and CD1a/T6 antigens and exhibit normal alloantigen-presenting capacity. Ashworth J; Kahan MC; Breathnach SM J Invest Dermatol; 1989 Feb; 92(2):258-62. PubMed ID: 2783952 [TBL] [Abstract][Full Text] [Related]
9. Ontogeny of Langerhans cells in human embryonic and fetal skin: expression of HLA-DR and OKT-6 determinants. Foster CA; Holbrook KA; Farr AG J Invest Dermatol; 1986 Mar; 86(3):240-3. PubMed ID: 2427603 [TBL] [Abstract][Full Text] [Related]
10. Morphological and quantitative analyses of normal epidermal Langerhans cells using confocal scanning laser microscopy. Yu RC; Abrams DC; Alaibac M; Chu AC Br J Dermatol; 1994 Dec; 131(6):843-8. PubMed ID: 7857837 [TBL] [Abstract][Full Text] [Related]
11. HLA-DM is expressed on the cell surface and colocalizes with HLA-DR and invariant chain in human Langerhans cells. Andersson T; Patwardhan A; Emilson A; Carlsson K; Scheynius A Arch Dermatol Res; 1998 Dec; 290(12):674-80. PubMed ID: 9879837 [TBL] [Abstract][Full Text] [Related]
12. Femtosecond two-photon high-resolution 3D imaging, spatial-volume rendering and microspectral characterization of immunolocalized MHC-II and mLangerin/CD207 antigens in the mouse epidermis. Tirlapur UK; Mulholland WJ; Bellhouse BJ; Kendall M; Cornhill JF; Cui Z Microsc Res Tech; 2006 Oct; 69(10):767-75. PubMed ID: 16941665 [TBL] [Abstract][Full Text] [Related]
13. Comparison between the L-DOPA histofluorescence procedure and the indirect immunofluorescence with anti-T6 and -HLA-DR monoclonal antibodies in visualizing Langerhans cells of human epidermis. Crivellato E; Damiani D; Mallardi F Acta Histochem; 1990; 88(1):59-64. PubMed ID: 2113342 [TBL] [Abstract][Full Text] [Related]
14. Regulation of immune activity by mild (fever-range) whole body hyperthermia: effects on epidermal Langerhans cells. Ostberg JR; Patel R; Repasky EA Cell Stress Chaperones; 2000 Nov; 5(5):458-61. PubMed ID: 11189452 [TBL] [Abstract][Full Text] [Related]
15. Multiphoton high-resolution 3D imaging of Langerhans cells and keratinocytes in the mouse skin model adopted for epidermal powdered immunization. Mulholland WJ; Arbuthnott EA; Bellhouse BJ; Cornhill JF; Austyn JM; Kendall MA; Cui Z; Tirlapur UK J Invest Dermatol; 2006 Jul; 126(7):1541-8. PubMed ID: 16645596 [TBL] [Abstract][Full Text] [Related]
16. Distinct behavior of human Langerhans cells and inflammatory dendritic epidermal cells at tight junctions in patients with atopic dermatitis. Yoshida K; Kubo A; Fujita H; Yokouchi M; Ishii K; Kawasaki H; Nomura T; Shimizu H; Kouyama K; Ebihara T; Nagao K; Amagai M J Allergy Clin Immunol; 2014 Oct; 134(4):856-64. PubMed ID: 25282566 [TBL] [Abstract][Full Text] [Related]
17. Comparative study of Langerhans cells in normal and pathological human scars. II. Hypertrophic scars. Cracco C; Stella M; Teich Alasia S; Filogamo G Eur J Histochem; 1992; 36(1):53-65. PubMed ID: 1374665 [TBL] [Abstract][Full Text] [Related]
18. Fragrance and contact allergens in vitro modulate the HLA-DR and E-cadherin expression on human epidermal Langerhans cells. Verrier AC; Schmitt D; Staquet MJ Int Arch Allergy Immunol; 1999 Sep; 120(1):56-62. PubMed ID: 10529589 [TBL] [Abstract][Full Text] [Related]
19. Flow cytometric analysis and sorting of HLA-DR+CD1+ Langerhans cells. Ashworth J; Kahan MC; Breathnach SM Br J Dermatol; 1989 Jul; 121(1):11-8. PubMed ID: 2474321 [TBL] [Abstract][Full Text] [Related]
20. Functional and phenotypic analysis of isolated human Langerhans cells and indeterminate cells. Czernielewski JM; Schmitt D; Faure MR; Thivolet J Br J Dermatol; 1983 Feb; 108(2):129-38. PubMed ID: 6186266 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]